NCT00311675View on ClinicalTrials.gov

St. Jude Open Label H5 Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

Monovalent subvirion H5N1 vaccine (HA of A/Vietnam/1203/04) provided in single-dose vials containing 90-mcg/mL A/H5N1 HA. Dosage is two 90 mcg doses administered intramuscularly separated by approximately 28 days.

Trial Locations (1)

31805

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00311675 - St. Jude Open Label H5 Trial | Biotech Hunter | Biotech Hunter